rs2470890 — CYP1A2 Asn516= (exon 7)
Synonymous variant in CYP1A2 exon 7 in linkage disequilibrium with the *1F high-inducibility haplotype; carriers activate more heterocyclic amines and PAHs from cooked meat and smoke into DNA-damaging intermediates
Details
- Gene
- CYP1A2
- Chromosome
- 15
- Risk allele
- T
- Consequence
- Synonymous
- Inheritance
- Codominant
- Clinical
- Risk Factor
- Evidence
- Strong
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Related SNPs
Category
Cancer RiskSee your personal result for CYP1A2
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
CYP1A2 Asn516= — The Carcinogen Activator in Your Kitchen
Cytochrome P450 1A2 (CYP1A2) accounts for roughly 13% of all cytochrome
P450 protein in the human liver and is the principal enzyme responsible for
N-oxidation of heterocyclic amines (HCAs)11 N-oxidation of heterocyclic amines (HCAs)
HCAs are mutagenic compounds
formed when creatine, amino acids, and sugars in meat react at high
temperatures — grilling, pan-frying, and broiling produce the highest
levels. This first metabolic
step converts dietary HCAs like
PhIP and MeIQx22 PhIP and MeIQx
PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine)
and MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline) are the two
most abundant HCAs in cooked meat from relatively inert compounds
into reactive N-hydroxy intermediates that can form DNA adducts and
initiate carcinogenesis.
The rs2470890 variant (c.1548T>C, p.Asn516=) is a synonymous change in
exon 7 of CYP1A2 that does not alter the amino acid sequence but sits
in strong linkage disequilibrium with the
CYP1A2*1F haplotype33 CYP1A2*1F haplotype
Defined by rs762551 (-163C>A) in intron 1, the
*1F haplotype is the most studied CYP1A2 variant for enzyme
inducibility. The T allele
at rs2470890 tags the high-inducibility form of CYP1A2: carriers
upregulate CYP1A2 expression more aggressively in response to inducers
— smoking, charred food, and cruciferous vegetables.
The Mechanism
CYP1A2 inducibility is controlled by the
aryl hydrocarbon receptor (AHR)44 aryl hydrocarbon receptor (AHR)
A ligand-activated transcription
factor that senses environmental chemicals and dietary compounds,
then activates detoxification gene expression through xenobiotic
response elements. When HCAs, PAHs from charred meat, or
glucosinolate breakdown products from cruciferous vegetables bind AHR,
it translocates to the nucleus and drives CYP1A2 transcription. The
*1F haplotype (tagged by the rs2470890 T allele) enhances this
induction response — meaning the enzyme ramps up more and faster
when exposed to inducers.
This creates a double-edged metabolic profile. On one hand, high CYP1A2
inducibility means faster clearance of caffeine and certain medications
(clozapine, theophylline, melatonin). On the other hand, it means
faster activation of dietary procarcinogens. The N-hydroxy-HCA
intermediates produced by CYP1A2 are then further activated by
N-acetyltransferases (NAT1, NAT2)55 N-acetyltransferases (NAT1, NAT2)
Phase II enzymes that attach
acetyl groups to N-hydroxy-HCAs, creating highly reactive
N-acetoxy esters capable of forming covalent DNA
adducts into forms
that directly damage DNA. The critical variable is whether Phase II
conjugation enzymes — particularly glutathione S-transferases — can
neutralize these intermediates before they reach DNA.
The Evidence
Colorectal cancer — the gene-diet-smoking triad. The landmark
population-based case-control study by Le Marchand et al.66 population-based case-control study by Le Marchand et al.
Le
Marchand L et al. Combined effects of well-done red meat, smoking,
and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing
colorectal cancer risk. Cancer Epidemiol Biomarkers Prev,
2001 studied 349
colorectal cancer cases and 467 controls in Hawaii. Among
ever-smokers who preferred well-done red meat and had both rapid
CYP1A2 and rapid NAT2 phenotypes, colorectal cancer risk was
8.8-fold elevated (95% CI 1.7-44.9) compared with smokers with
slow metabolizer phenotypes who ate rare or medium meat. This dramatic
effect illustrates how genotype, diet, and smoking converge: smoking
induces CYP1A2, well-done meat provides HCA substrate, and rapid
CYP1A2 converts that substrate into carcinogenic intermediates.
Prostate cancer — protection vs progression paradox. A
study of 522 prostate cancer patients and 554 controls77 study of 522 prostate cancer patients and 554 controls
Vilckova M
et al. Polymorphisms in the gene encoding CYP1A2 influence prostate
cancer risk and progression. Oncol Lett,
2023 found that the
CC genotype (low inducibility, homozygous alternate) was associated
with decreased prostate cancer risk in the recessive model (OR 0.67,
95% CI 0.48-0.93). However, among men who did develop prostate
cancer, the T allele was associated with higher Gleason scores
(OR 1.36, P=0.04) and more advanced pathological stage (OR 2.31,
P=0.004). This suggests that high CYP1A2 inducibility may not
only contribute to cancer initiation through carcinogen activation
but may also drive more aggressive tumor biology.
Breast cancer prognosis. A
study of 459 breast cancer patients in northern China88 study of 459 breast cancer patients in northern China
Bai X
et al. The associations of genetic polymorphisms in CYP1A2 and
CYP3A4 with clinical outcomes of breast cancer patients in
northern China. Oncotarget,
2017 found that TT
carriers had significantly worse overall survival compared with
CC carriers (HR 3.41, 95% CI 1.54-7.58, P=0.003). The variant
also correlated with CYP1A2 protein expression levels, confirming
a functional impact on enzyme abundance in tumor tissue.
Overall cancer risk. Population-level meta-analyses that pool all CYP1A2 polymorphisms without stratifying by dietary HCA exposure find no significant overall association with cancer. This null overall result masks the critical gene-environment interaction: CYP1A2 variants only become cancer risk factors when combined with HCA/PAH exposure from diet and smoking. Studies that do not stratify by exposure miss the signal entirely.
Practical Implications
The key insight from this research is that CYP1A2 high inducibility is not a cancer risk gene in isolation — it becomes dangerous specifically when combined with dietary carcinogen exposure. The 8.8-fold risk increase in the Le Marchand study required three factors simultaneously: rapid CYP1A2 phenotype, well-done meat preference, and smoking history. Remove any one of these, and the risk drops substantially.
This makes the variant highly actionable. Unlike many cancer risk
SNPs where the only advice is surveillance, carriers of the high-
inducibility genotype can directly reduce their risk by modifying
how they prepare meat. Marinating before grilling reduces HCA
formation by
57-88%99 57-88%
Smith JS et al. Effect of marinades on the formation
of heterocyclic amines in grilled beef steaks. J Food Sci,
2008. Cruciferous
vegetables provide sulforaphane that
upregulates Phase II detoxification enzymes1010 upregulates Phase II detoxification enzymes
Nho CW and Jeffery
E. The synergistic upregulation of phase II detoxification enzymes
by glucosinolate breakdown products in cruciferous vegetables.
Toxicol Appl Pharmacol,
2001 — glutathione
S-transferases and quinone reductase — which conjugate and neutralize
the reactive intermediates that CYP1A2 generates.
Interactions
CYP1A2 rs762551 (*1F intronic tag SNP): The rs2470890 T allele is in strong linkage disequilibrium with the rs762551 A allele, which defines the *1F haplotype. Together these variants tag the high-inducibility CYP1A2 phenotype. The rs762551 entry in the pharmacogenomics category covers the caffeine metabolism angle; this entry focuses on the carcinogen activation consequences of the same underlying biology.
CYP1A1 rs1048943 (Ile462Val): CYP1A1 activates polycyclic aromatic hydrocarbons while CYP1A2 activates heterocyclic amines. Both produce reactive intermediates requiring Phase II conjugation. Carriers with high-activity variants in both enzymes face compounded carcinogen activation capacity. The Vineis et al. (2003) pooled analysis found that CYP1A1 Val allele combined with GSTM1 null genotype yielded OR 4.67 for lung cancer — illustrating how Phase I overactivity plus Phase II deficiency amplifies risk. A similar principle applies when CYP1A2 high inducibility co-occurs with CYP1A1 Val462.
NAT2 rapid acetylator status: The Le Marchand study showed that the cancer risk from CYP1A2 rapid phenotype was strongest when combined with rapid NAT2, because NAT2 catalyzes the second activation step (O-acetylation) that converts N-hydroxy-HCAs into DNA-reactive esters. CYP1A2 and NAT2 act sequentially in the same pathway.
Drug Interactions
Nutrient Interactions
Genotype Interpretations
What each possible genotype means for this variant:
Lower CYP1A2 induction response — reduced carcinogen activation from cooked meat
The CC genotype at rs2470890 tags a CYP1A2 haplotype with lower inducibility compared to the T-allele-carrying *1F-linked haplotype. In the Slovak prostate cancer study (Vilckova et al. 2023), this genotype was associated with a significantly decreased risk of prostate cancer in the recessive model (OR 0.67, 95% CI 0.48-0.93, P=0.02). The Chinese breast cancer study found CC carriers had the best overall survival compared with other genotypes.
Lower inducibility means CYP1A2 expression increases less when exposed to dietary and environmental inducers. Since CYP1A2 catalyzes the N-oxidation step that activates heterocyclic amines into carcinogenic intermediates, less induction translates to less carcinogen activation — particularly relevant for those who consume grilled or charred meats.
Note that lower CYP1A2 inducibility also means slower caffeine clearance under inducing conditions. The pharmacogenomic implications of CYP1A2 activity for caffeine and medication metabolism are covered under rs762551 in the pharmacogenomics category.
One copy of the high-inducibility allele — moderately increased carcinogen activation
With one copy of the T allele, you carry one chromosome with the *1F-linked high-inducibility haplotype. When exposed to CYP1A2 inducers — compounds from charred food, cigarette smoke, or cruciferous vegetables — your enzyme upregulation is intermediate between CC and TT carriers.
The functional impact of the heterozygous state depends heavily on environmental exposure. In the Le Marchand et al. (2001) study, the gene-environment interaction required both rapid CYP1A2 phenotype and high dietary HCA exposure to drive colorectal cancer risk. Heterozygous carriers who minimize charred food intake and avoid smoking substantially reduce the pool of HCA substrate available for CYP1A2 activation.
This genotype also has intermediate implications for caffeine metabolism. Under inducing conditions (regular coffee consumption, smoking), CYP1A2 activity increases more than in CC carriers but less than in TT carriers.
Two copies of the high-inducibility allele — maximal carcinogen activation from cooked meat and smoke
With both copies carrying the T allele, your CYP1A2 induction response is at its highest. When you eat charred or well-done meat, smoke cigarettes, or are exposed to environmental PAHs, your CYP1A2 expression increases more than in CT or CC carriers. This means faster N-oxidation of heterocyclic amines (PhIP, MeIQx, DiMeIQx) into their N-hydroxy forms — the first activation step on the pathway to DNA adduct formation.
The Le Marchand et al. (2001) study demonstrated the clinical impact: ever-smokers with rapid CYP1A2 and NAT2 phenotypes who preferred well-done red meat had an 8.8-fold elevated colorectal cancer risk. The TT genotype at rs2470890 tags this rapid CYP1A2 phenotype.
In prostate cancer, the Vilckova et al. (2023) study found that TT carriers who developed cancer had more aggressive tumors: higher Gleason scores (OR 1.36) and more advanced pathological stage (OR 2.31, P=0.004). In breast cancer, TT carriers had significantly worse overall survival (HR 3.41, 95% CI 1.54-7.58).
The functional impact extends beyond cancer. The clozapine study (Viikki et al. 2014) found TT carriers experienced significantly more drug side effects, confirming that this genotype has measurable effects on CYP1A2-mediated drug metabolism as well.
Crucially, the cancer risk is exposure-dependent. Studies that do not stratify by dietary HCA intake and smoking status find no overall association with cancer. The genotype only matters when there is carcinogenic substrate to activate — making this one of the most actionable cancer-risk variants in the genome.
Key References
Le Marchand et al. 2001 — population-based case-control study (349 cases, 467 controls) found 8.8-fold colorectal cancer risk (95% CI 1.7-44.9) in ever-smokers with rapid CYP1A2 + NAT2 phenotypes who preferred well-done red meat
Vilckova et al. 2023 — 522 prostate cancer cases and 554 controls; rs2470890 CC genotype associated with decreased prostate cancer risk (OR 0.67, 95% CI 0.48-0.93, P=0.02 recessive model), but TT associated with higher Gleason score (OR 1.36, P=0.04) and advanced pathological stage (OR 2.31, P=0.004)
Zheng and Lee 2009 — review of 21 epidemiological studies showing high intake of well-done meat and HCA exposure increases cancer risk across colorectal, breast, prostate, and pancreatic cancers, with CYP1A2 rapid phenotype as key modifier
Smith et al. 2008 — marinades reduced HCA formation in grilled beef steaks by 57-88%; Caribbean marinade achieved 88% reduction attributed to polyphenolic antioxidants (carnosic acid, rosmarinic acid)
Bu et al. 2014 — meta-analysis of four CYP1A2 polymorphisms and lung cancer; rs2470890 showed no significant association (3 studies, 691 cases, 968 controls), unlike rs762551 which reached significance in Caucasians
Viikki et al. 2014 — rs2470890 TT genotype associated with increased side effects to clozapine (P=0.011) in 180 patients, confirming functional impact on CYP1A2 activity
Bai et al. 2017 — 459 breast cancer patients in northern China; rs2470890 TT carriers had significantly worse overall survival vs CC (HR 3.41, 95% CI 1.54-7.58, P=0.003); variant correlated with CYP1A2 protein expression levels